GoodRx Holdings Resultados de beneficios anteriores
Pasado controles de criterios 0/6
GoodRx Holdings ha aumentado sus beneficios a una tasa media anual de 1.8%, mientras que los beneficios de la industria de Healthcare Services han experimentado un crecimiento anual de 2.8%. Los ingresos han ido creciendo a una tasa media de 16.8% al año.
Información clave
1.8%
Tasa de crecimiento de los beneficios
-1.9%
Tasa de crecimiento del BPA
Crecimiento de la industria Healthcare Services | 1.7% |
Tasa de crecimiento de los ingresos | 16.8% |
Rentabilidad financiera | -1.2% |
Margen neto | -1.2% |
Próxima actualización de resultados | 09 May 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
GoodRx Holdings: Large TAM Continues To Support Growth
Mar 20GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Mar 07Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?
Mar 01GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet
Feb 12GoodRx: Cost Saving Is A Strong Value Proposition To Consumers
Jan 23GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital
Jan 22GoodRx Stock Spikes After Receiving A Strong Dose Of Performance
Jan 11What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?
Dec 02GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital
Sep 12An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued
Jul 14GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business
May 27Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%
May 05Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding
May 05Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?
Mar 23GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital
Feb 07GoodRx Holdings (NASDAQ:GDRX) Could Be Struggling To Allocate Capital
Nov 02GoodRx laying off 140 employees, 16% of workforce
Aug 31GoodRx: Trending Positive, But Not A Buy Yet
Aug 25GoodRx: Unexpected Short Squeeze As Grocer Issue Resolved
Aug 09GoodRx: Unexpected Wrench Pushes Me To The Sidelines
Jul 25Here's What's Concerning About GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital
Jul 20GoodRx: Guidance Gets Worse, Stay Clear
May 19GoodRx: Time To Buy The Dip
Apr 23Returns On Capital Signal Tricky Times Ahead For GoodRx Holdings (NASDAQ:GDRX)
Apr 19Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero GoodRx Holdings. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
31 Dec 23 | 750 | -9 | 451 | 126 |
30 Sep 23 | 738 | 15 | 418 | 141 |
30 Jun 23 | 745 | 12 | 427 | 137 |
31 Mar 23 | 747 | -48 | 448 | 141 |
31 Dec 22 | 767 | -33 | 465 | 143 |
30 Sep 22 | 796 | -71 | 519 | 141 |
30 Jun 22 | 803 | -47 | 515 | 141 |
31 Mar 22 | 788 | -15 | 513 | 135 |
31 Dec 21 | 745 | -25 | 525 | 126 |
30 Sep 21 | 686 | -282 | 792 | 114 |
30 Jun 21 | 631 | -314 | 833 | 95 |
31 Mar 21 | 578 | -310 | 764 | 78 |
31 Dec 20 | 551 | -294 | 715 | 62 |
30 Sep 20 | 510 | 13 | 357 | 48 |
30 Jun 20 | 472 | 75 | 234 | 40 |
31 Mar 20 | 435 | 50 | 217 | 34 |
31 Dec 19 | 388 | 42 | 192 | 29 |
31 Dec 18 | 250 | 14 | 113 | 44 |
Ingresos de calidad: GDRX is currently unprofitable.
Margen de beneficios creciente: GDRX is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: GDRX is unprofitable, but has reduced losses over the past 5 years at a rate of 1.8% per year.
Acelerando crecimiento: Unable to compare GDRX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: GDRX no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Healthcare Services (15.4%).
Rentabilidad financiera
Alta ROE: GDRX tiene una rentabilidad financiera negativa (-1.16%), ya que actualmente no es rentable.